Treatments and Outcomes of Adult Patients with AML in the Real-Life - First Report of the French Observational ALFA-PPP StudyHervé Dombret, Stéphane de Botton, Alexandra Coelho et al.|Blood|2024Cited by 0
Real life treatments and outcomes of older patients aged more than 60 years with FLT3-mutated acute myeloid leukemia: Report from the multicentric french observational ALFA-PPP studyRamy Rahmé, Thorsten Braun, Emmanuel Raffoux et al.|Blood|2025Cited by 0
Real-world patterns of treatment intensity and prognostic model performance in older AML: Insights from the french ALFA-PPP cohortLin-Pierre Zhao, Lionel Adès, Thorsten Braun et al.|Blood|2025Cited by 0
Real-world patterns of treatment intensity and prognostic model performance in older acute myeloid leukemia: insights from the French ALFA-PPP CohortLin‐Pierre Zhao, Lionel Adès, Nicolas Duployez et al.|Leukemia|2026Cited by 0